Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Study of Nomacopan (rVA576) in Paediatric Haematopoietic Stem-Cell Transplant Associated Thrombotic Microangiopathy

NCT04784455 is registered in ClinicalTrials.gov with AKARI Therapeutics as lead sponsor.

NCT NCT04784455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04784455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Study of Nomacopan (rVA576) in Paediatric Haematopoietic Stem-Cell Transplant Associated Thrombotic Microangiopathy
Lead sponsor
AKARI Therapeutics
Phase
Phase 3
Overall status
Terminated
Start date
February 1, 2021
Completion date
May 15, 2024
Enrollment
10 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

thrombotic microangiopathies